Impact of nanotechnology on drug delivery

ACS Nano

Volumn 3, Issue 1, 2009, Pages 16-20

  Farokhzad, Omid C ^a   Langer, Robert ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENGINEERING AND MANUFACTURING; INDIVIDUAL COMPONENTS; MOLECULAR SCALE; NATIONAL NANOTECHNOLOGY INITIATIVES; ONE DIMENSIONS; TOP DOWNS;

DRUG DELIVERY;

NANOTECHNOLOGY;

DRUG; DRUG CARRIER; LIPOSOME; NANOMATERIAL; NANOPARTICLE;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DESIGN; HUMAN; METHODOLOGY; NANOTECHNOLOGY; NEOPLASM; REVIEW;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; LIPOSOMES; MODELS, MOLECULAR; NANOPARTICLES; NANOSTRUCTURES; NANOTECHNOLOGY; NEOPLASMS; PHARMACEUTICAL PREPARATIONS;

EID: 61849153021     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn900002m     Document Type: Article

References (37)

1. Whitesides, G. M. The 'Right' Size in Nanobiotechnology. Nat. Biotechnol. 2003, 21, 1161-1165.
2. LaVan, D. A.; McGuire, T.; Langer, R. Small-Scale Systems for in vivo Drug Delivery. Nat. Biotechnol. 2003, 21, 1184-1191.
3. Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges. Nat. Rev. Cancer 2005, 5, 161-171.
4. Farokhzad, O. C.; Karp, J. M.; Langer, R. Nanoparticle - Aptamer Bioconjugates for Cancer Targeting. Exp. Opin. Drug Delivery 2006, 3, 311-324.
5. Zhang, L.; Gu, F. X.; Chan, J. M.; Wang, A. Z.; Langer, R. S.; Farokhzad, O. C. Nanoparticles in Medicine: Therapeutic Applications and Developments. Clin. Pharmacol. Ther. 2008, 83, 761-769.
6. Langer, R. Drug Delivery and Targeting. Nature 1998, 392, 5-10.
7. Langer, R. New Methods of Drug Delivery. Science 1990, 249, 1527-1533.
8. Glass, G. Pharmaceutical Patent Challenges - Time for Reassessment. Nat. Rev. Drug Discovery 2004, 3, 1057-1062.
9. Liong, M.; Lu, J.; Kovochich, M.; Xia, T.; Ruehm, S. G.; Nel, A. E.; Tamanoi, F.; Zink, J. I. Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery. ACS Nano 2008, 2, 889-896.
10. Bangham, A. D.; Standish, M. M.; Watkins, J. C. Diffusion of Univalent Ions Across the Lamellae of Swollen Phospholipids. J. Mol. Biol. 1965, 13, 238-252.
11. Langer, R.; Folkman, J. Polymers for the Sustained Release of Proteins and Other Macromolecules. Nature 1976, 263, 797-800.
12. Yatvin, M. B.; Kreutz, W.; Horwitz, B. A.; Shinitzky, M. pH-Sensitive Liposomes: Possible Clinical Implications. Science 1980, 210, 1253-1255.
13. Leserman, L. D.; Barbet, J.; Kourilsky, F.; Weinstein, J. N. Targeting to Cells of Fluorescent Liposomes Covalently Coupled with Monoclonal Antibody or Protein A. Nature 1980, 288, 602-604.
14. Heath, T. D.; Fraley, R. T.; Papahdjopoulos, D. Antibody Targeting of Liposomes: Cell Specificity Obtained by Conjugation of F(ab′)2 to Vesicle Surface. Science 1980, 210, 539-541.
15. Allen, T. M.; Chonn, A. Large Unilamellar Liposomes with Low Uptake into the Reticuloendothelial System. FEBS Lett. 1987, 223, 42-46.
16. Klibanov, A. L.; Maruyama, K.; Torchilin, V. P.; Huang, L. Amphipathic Polyethyleneglycols Effectively Prolong the Circulation Time of Liposomes. FEBS Lett. 1990, 268, 235-237.
17. Gref, R.; Minamitake, Y.; Peracchia, M. T.; Trubetskoy, V.; Torchilin, V.; Langer, R. Biodegradable Long-Circulating Polymeric Nanospheres. Science 1994, 263, 1600-1603.
18. Wagner, V.; Dullaart, A.; Bock, A.-K.; Zweck, A. The Emerging Nanomedicine Landscape. Nat. Biotechnol. 2006, 24, 1211-1217.
19. Mann, D. G. J.; McKnight, T. E.; McPherson, J. T.; Hoyt, P. R.; Melechko, A. V.; Simpson, M. L.; Sayler, G. S. Inducible RNA Interference-Mediated Gene Silencing Using Nanostructured Gene Delivery Arrays. ACS Nano 2008, 2, 69-76.
20. Gu, F.; Zhang, L.; Teply, B. A.; Mann, N.; Wang, A.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Precise Engineering of Targeted Nanoparticles by Using Self-Assembled Biointegrated Block Copolymers. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 2586-2591.
21. Decuzzi, P.; Pasqualini, R.; Arap, W.; Ferrari, M. Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? Pharm. Res. 2009, 1, 235-243.
22. Patil, Y. B.; Stoti, U. S.; Khdair, A.; Ma, L.; Panyam, J. Single-Step Surface Functionalization of Polymeric Nanoparticles for Targeted Drug Delivery. Biomaterials 2008, 30, 859-866.
23. Kim, B.-S.; Park, S. W.; Hammond, P. T. Hydrogen-Bonding Layer-by-Layer-Assembled Biodegradable Polymeric Micelles as Drug Delivery Vehicles from Surfaces. ACS Nano 2008, 2, 386-392.
24. Verma, A.; Uzun, O.; Hu, Y.; Hu, Y.; Han, H. S.; Watson, N.; Chen, S.; Irvine, D. J.; Stellacci, F. Surface-Structure-Regulated Cell-Membrane Penetration by Monolayer-Protected Nanoparticles. Nat. Mater. 2008, 7, 588-595.
25. Gratton, S. E.; Ropp, P. A.; Pohlhaus, P. D.; Luft, J. C.; Madden, V. J.; Napier, M. E.; DeSimone, J. M. The Effect of Particle Design on Cellular Internalization Pathways. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 11613-11618.
26. Dreher, M. R.; Liu, W.; Michelich, C. R.; Dewhirst, M. W.; Yuan, F.; Chilkoti, A. Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers. J. Natl. Cancer Inst. 2006, 98, 335-344.
27. Matsumura, Y.; Maeda, H. A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs. Cancer Res. 1986, 46, 6387-6392.
28. Pun, S. H.; Tack, F.; Bellocq, N. C.; Cheng, J.; Grubbs, B. H.; Jensen, G. S.; Davis, M. E.; Brewster, M.; Janicot, M.; Janssens, B.; et al. Targeted Delivery of RNA-Cleaving DNA Enzyme (DNAzyme) to Tumor Tissue by Transferrin-Modified, Cyclodextrin-Based Particles. Cancer Biol. Ther. 2004, 3, 641-650.
29. Pirollo, K. F.; Chang, E. H. Does a Targeting Ligand Influence Nanoparticle Tumor Localization or Uptake? Trends Biotechnol. 2008, 26, 552-558.
30. Kirpotin, D. B.; Drummond, D. C.; Shao, Y.; Shalaby, M. R.; Hong, K.; Nielsen, U. B.; Marks, J. D.; Benz, C. C.; Park, J. W. Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models. Cancer Res. 2006, 66, 6732-6740.
31. Hussain, S.; Plückthun, A.; Allen, T. M.; Zangemeister-Wittke, U. Antitumor Activity of an Epithelial Cell Adhesion Molecule-Targeted Nanovesicular Drug Delivery System. Mol. Cancer Ther. 2007, 6, 3019-3027.
32. Jain, R. K. Delivery of Molecular and Cellular Medicine to Solid Tumors. Adv. Drug Delivery Rev. 2001, 46, 149-168.
33. Alexis, F.; Pridgen, E.; Molnar, L. K.; Farokhzad, O. C. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles. Mol. Pharm. 2008, 5, 505-515.
34. Farokhzad, O. C.; Cheng, J.; Teply, B. A.; Sherifi, I.; Jon, S.; Kantoff, P. W.; Richie, J. P.; Langer, R. Targeted Nanoparticle-Aptamer Bioconjugates for Cancer Chemotherapy in vivo. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 6315-6320.
35. Zhang, N.; Chittasupho, C.; Duangrat, C.; Siahaan, T. J.; Berkland, C. PLGA Nanoparticle - Peptide Conjugate Effectively Targets Intercellular Cell-Adhesion Molecule-1. Bioconjugate Chem. 2008, 19, 145-152.
36. Reddy, S. T.; van der Vlies, A. J.; Simeoni, E.; Angeli, V.; Randolph, G. J.; O'Neil, C. P.; Lee, L. K.; Swartz, M. A.; Hubbell, J. A. Exploiting Lymphatic Transport and Complement Activation in Nanoparticle Vaccines. Nat. Biotechnol. 2007, 25, 1159-1164.
37. Calando Pharmaceuticals: http://www.insertt.com.